BPMC - Blueprint Medicines started at buy by Stephens citing Ayvakit franchise
2024-05-14 13:35:41 ET
More on Blueprint Medicines
- Blueprint Medicines: Rampant Growth Mostly Priced In
- Blueprint Medicines Corporation (BPMC) Q1 2024 Earnings Call Transcript
- Blueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentation
- Blueprint Medicines GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M
- Blueprint Medicines Q1 2024 Earnings Preview